Data as of Nov 28
| -0.85 / -0.59%|
The 1 analysts offering 12-month price forecasts for Taro Pharmaceutical Industries Ltd have a median target of 190.00, with a high estimate of 190.00 and a low estimate of 190.00. The median estimate represents a +32.41% increase from the last price of 143.49.
The current consensus among 1 polled investment analysts is to Buy stock in Taro Pharmaceutical Industries Ltd. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.